Insider Transactions in Q3 2021 at Agilon Health, Inc. (AGL)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2021
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
121,001
-31.6%
|
$3,388,028
$28.98 P/Share
|
|
Sep 14
2021
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
121,001
+24.01%
|
$121,001
$1.0 P/Share
|
|
Sep 14
2021
|
Lisa Dombro Exper. & Innovation Officer |
SELL
Open market or private sale
|
Direct |
61,543
-83.73%
|
$1,723,204
$28.98 P/Share
|
|
Sep 14
2021
|
Lisa Dombro Exper. & Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,543
+45.57%
|
$61,543
$1.0 P/Share
|
|
Sep 14
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-100.0%
|
$2,800,000
$28.98 P/Share
|
|
Sep 14
2021
|
Theodore Halkias Chief Business Officer |
SELL
Open market or private sale
|
Direct |
58,553
-91.51%
|
$1,639,484
$28.98 P/Share
|
|
Sep 14
2021
|
Theodore Halkias Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,553
+47.78%
|
$58,553
$1.0 P/Share
|
|
Sep 14
2021
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
11,475
-67.86%
|
$321,300
$28.98 P/Share
|
|
Sep 14
2021
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,475
+40.43%
|
$45,900
$4.5 P/Share
|
|
Sep 14
2021
|
Sharad Mansukani Director |
SELL
Open market or private sale
|
Direct |
156,250
-11.28%
|
$4,375,000
$28.98 P/Share
|
|
Sep 14
2021
|
Sharad Mansukani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
156,250
+10.13%
|
$156,250
$1.0 P/Share
|
|
Sep 14
2021
|
Steven Sell CEO & President |
SELL
Open market or private sale
|
Direct |
100,000
-100.0%
|
$2,800,000
$28.98 P/Share
|
|
Sep 14
2021
|
Steven Sell CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$400,000
$4.5 P/Share
|
|
Sep 14
2021
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
73,018
-39.13%
|
$2,044,504
$28.98 P/Share
|
|
Sep 14
2021
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,018
+28.12%
|
$73,018
$1.0 P/Share
|
|
Sep 14
2021
|
John William Wulf Director |
SELL
Open market or private sale
|
Direct |
15,342
-9.44%
|
$429,576
$28.98 P/Share
|
|
Sep 14
2021
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,904,257
-8.0%
|
$501,319,196
$28.98 P/Share
|
|
Sep 09
2021
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
865,112
-0.39%
|
-
|
|
Sep 09
2021
|
Richard J Schnall Director |
SELL
Bona fide gift
|
Direct |
119,989
-100.0%
|
-
|
|
Sep 09
2021
|
Richard J Schnall Director |
BUY
Other acquisition or disposition
|
Direct |
119,989
+50.0%
|
-
|
|
Jul 14
2021
|
Karen Mc Loughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,489
+50.0%
|
-
|